2m 2m 2m 2m 2m 2m 2m
PTC Therapeutics (PTCT)
NASDAQ
$82.20+$1.24 (+1.53%)
Price as of Jun 23, 2026 6:41 PM EDT- $6.7BMarket Cap
- 63.23%1-Year Change
- BiotechnologyIndustry
PTC Therapeutics (PTCT)
$82.20+$1.24 (+1.53%)
PTCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $80.96 | ||
Change | +$1.98 (+2.51%) | ||
Open | $80.00 | ||
High | $81.71 | ||
Low | $79.50 | ||
Previous Close | $78.98 | ||
Volume | 2,414,051 | ||
30-Day Average Volume | 1,910,677 | ||
1-Week Change | 5.46% | ||
1-Month Change | 17.66% | ||
1-Year Change | 63.23% | ||
3-Year Change | 93.13% | ||
5-Year Change | 87.10% | ||
Fundamentals | |||
Shares Outstanding | 82.9M | ||
Total Assets | $2.9B | ||
Market Cap | $6.7B | ||
Enterprise Value | $6.5B | ||
Period: QTR TTM FY | |||
Revenue | $225.6M | ||
Net Income | -$2.8M | ||
Free Cash Flow | -$60.2M | ||
EBIT | $46.6M | ||
EBITDA | $62.0M | ||
Net Working Capital | $1.3B | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | 104 | ||
Enterprise Value/Revenue | 29 | ||
P/B | -37 | ||
P/E | -2,699 | ||
PEG | -28 | ||
Price/Free Cash Flow | -111 | ||
Price/Operating Cash Flow | -114 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue